4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000013
EVP Strategy and Corporate Dev sold 1,532 shares at an average $234.32 ($358,971)
From the SEC's structured data for this filing
Trades in this filing
Pacelli Steven Robert · EVP Strategy and Corporate Dev
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-23 | Sale : show line 1 in the form | −732 | $233.17 | $170,680 | 76,955 | D |
| 2020-01-23 | Sale : show line 2 in the form | −300 | $234.26 | $70,279 | 76,655 | D |
| 2020-01-23 | Sale : show line 3 in the form | −500 | $236.03 | $118,013 | 76,155 | D |
| Open-market sales · 1,532 sh · avg $234.32 · $358,971 | ||||||
Loading xslF345X03/edgardoc.xml…